Epigenetic heterogeneity of B-cell lymphoma: Chromatin modifiers

Genes

Volumn 6, Issue 4, 2015, Pages 1076-1112

  Hopp, Lydia ^a   Nersisyan, Lilit ^b   Löffler Wirth, Henry ^a   Arakelyan, Arsen ^b,c   Binder, Hans ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

^c AMERICAN UNIVERSITY OF ARMENIA   (Armenia)

Author keywords

B cell maturation; Coupling between energy metabolism and epigenetics; Methylation of histone lysine side chains; Plasticity of cell function; Regulation of gene expression; Writers and erasers of epigenetic marks

Indexed keywords

2 HYDROXYGLUTARIC ACID; 2 OXOGLUTARIC ACID; CELL PROTEIN; DNA; DNA DEMETHYLATING ENZYME; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE; HISTONE DEMETHYLASE; HISTONE H3; HISTONE K36MT; HISTONE K4MT; HISTONE K79MT; HISTONE K9MT; HISTONE KMT2A; HISTONE KMT2B; HISTONE KMT3; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; PROTEIN KDM1A; PROTEIN KDM4A; PROTEIN KDM4B; PROTEIN KDM4D; PROTEIN KDM5B; PROTEIN KDM6A; PROTEIN KDM7A; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN MODIFIER; CITRIC ACID CYCLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; EPIGENETIC HETEROGENEITY; EPIGENETIC MODIFIER; EPIGENETICS; EZH2 GENE; FEEDBACK SYSTEM; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; METABOLIC REGULATION; METABOLITE; MLL2 GENE; MODIFIER GENE; PLASTICITY; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 84944902293     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes6041076     Document Type: Article

References (93)

1. Varier, R.A.; Timmers, H.T.M. Histone lysine methylation and demethylation pathways in cancer. Biochim. Biophys. Acta 2011, 1815, 75-89.
2. Sharma, S.; Kelly, T.K.; Jones, P.A. Epigenetics in cancer. Carcinogenesis 2010, 31, 27-36.
3. Noushmehr, H.; Weisenberger, D.J.; Diefes, K.; Phillips, H.S.; Pujara, K.; Berman, B.P.; Aldape, K. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17, 510-522.
4. Chi, P.; Allis, C.D.; Wang, G.G. Covalent histone modifications-Miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10, 457-469.
5. Shaknovich, R.; Melnick, A. Epigenetics and B-cell Lymphoma. Curr. Opin. Hematol. 2011, 18, 293-299.
6. Hopp, L.; Wirth-Loeffler, H.; Binder, H. Epigenetic heterogeneity of B-cell lymphoma: DNA-methylation, gene expression and chromatin states. Genes 2015, 6, 812-840.
7. Hummel, M.; Bentink, S.; Berger, H.; Klapper, W.; Wessendorf, S.; Barth, T.F.E. The molecular mechanisms in malignant lymphomas network project of the Deutsche Krebshilfe a biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 2006, 354, 2419-2430.
8. Martín-Subero, J.I.; Kreuz, M.; Bibikova, M.; Bentink, S.; Ammerpohl, O.; Wickham-Garcia, E.; Siebert, R. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 2009, 113, 2488-2497.
9. Wirth, H.; Loeffler, M.; von Bergen, M.; Binder, H. Expression cartography of human tissues using self organizing maps. BMC Bioinform. 2011, doi:10.1186/1471-2105-12-306.
10. Hopp, L.; Lembcke, K.; Binder, H.; Wirth, H. Portraying the expression landscapes of B-cell lymphoma--Intuitive detection of outlier samples and of molecular subtypes. Biology 2013, 2, 1411-1437.
11. Hopp, L.; Wirth, H.; Fasold, M.; Binder, H. Portraying the expression landscapes of cancer subtypes: A glioblastoma multiforme and prostate cancer case study. Syst. Biomed. 2013, 1, 99-121.
12. Wirth-Loeffler, H.; Hopp, L.; Kreuz, M.; Siebert, R.; Loeffler, M.; Binder, H. A holistic view on the expression landscape of Germinal center-derived B-cell lymphomas. Unpublished data, 2015.
13. Rosolowski, M.; Läuter, J.; Abramov, D.; Drexler, H.G.; Hummel, M.; Klapper, W.; Loeffler, M. Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas. PLoS ONE 2013, 8, e76287.
14. Wirth-Loeffler, H.; Kalcher, M.; Binder, H. oposSOM: R-package for high-dimensional portraying of genome-wide expression landscapes on Bioconductor. Bioinformatics 2015, 31, 3225-3227.
15. Wirth, H.; von Bergen, M.; Binder, H. Mining SOM expression portraits: Feature selection and integrating concepts of molecular function. BioData Mining 2012, doi:10.1186/1756-0381-5-18.
16. Arakelyan, A. High-throughput Gene Expression Analysis Concepts and Applications. In Sequence and Genome Analysis II-Bacteria, Viruses and Metabolic Pathways; iConcept Press: Hong Kong, China, 2013.
17. Arakelyan, A.; Nersisyan, L. KEGGParser: Parsing and editing KEGG pathway maps in Matlab. Bioinformatics 2013, 29, 518-519.
18. Binder, H.; Wirth, H.; Arakelyan, A.; Lembcke, K.; Tiys, E.S.; Ivanishenko, V.; Larina, I.M. Time-course human urine proteomics in space-flight simulation experiments. BMC Genomics 2014, doi:10.1186/1471-2164-15-S12-S2.
19. Thomson, J.P.; Skene, P.J.; Selfridge, J.; Clouaire, T.; Guy, J.; Webb, S.; Bird, A. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010, 464, 1082-1086.
20. Fujita, N.; Watanabe, S.; Ichimura, T.; Tsuruzoe, S.; Shinkai, Y.; Tachibana, M.; Nakao, M. Methyl- CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J. Biol. Chem. 2003, 278, 24132-24138.
21. Feldman, N.; Gerson, A.; Fang, J.; Li, E.; Zhang, Y.; Shinkai, Y.; Bergman, Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8, 188-194.
22. Ooi, S.K.T.; Qiu, C.; Bernstein, E.; Li, K.; Jia, D.; Yang, Z.; Bestor, T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448, 714-717.
23. Hagarman, J.A.; Motley, M.P.; Kristjansdottir, K.; Soloway, P.D. Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells. PLoS ONE 2013, 8, e53880.
24. Liu, H.; Chen, Y.; Lv, J.; Liu, H.; Zhu, R.; Su, J.; Wu, Q. Quantitative epigenetic co-variation in CpG islands and co-regulation of developmental genes. Sci. Rep. 2013, doi:10.1038/srep02576.
25. Köhler, C.; Villar, C.B.R. Programming of gene expression by Polycomb group proteins. Trends Cell Biol. 2008, 18, 236-243.
26. Klose, R.J.; Cooper, S.; Farcas, A.M.; Blackledge, N.P.; Brockdorff, N. Chromatin Sampling-An Emerging Perspective on Targeting Polycomb Repressor Proteins. PLoS Genet 2013, 9, e1003717.
27. Jeltsch, A.; Jurkowska, R.Z. New concepts in DNA methylation. Trends Biochem. Sci. 2014, 39, 310-318.
28. Schmitz, R.; Young, R.M.; Ceribelli, M.; Jhavar, S.; Xiao, W.; Zhang, M.; Staudt, L.M. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012, 490, 116-120.
29. Love, C.; Sun, Z.; Jima, D.; Li, G.; Zhang, J.; Miles, R.; Dave, S.S. The genetic landscape of mutations in Burkitt lymphoma. Nat. Genet 2012, 44, 1321-1325.
30. Sarris, M.; Nikolaou, K.; Talianidis, I. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation. Oncogene 2014, 33, 1207-1217.
31. Shen, H.; Laird, P.W. Interplay between the cancer genome and epigenome. Cell 2013, 153, 38-55.
32. Vaqué, J.P.; Martínez, N.; Batlle-López, A.; Pérez, C.; Montes-Moreno, S.; Sánchez-Beato, M.; Piris, M.A. B-Cell Lymphoma Mutations: Improving Diagnostics and Enabling Targeted Therapies. Haematologica 2014, 99, 222-231.
33. Chung, Y.; Schatoff, E.; Abdel-Wahab, O. Epigenetic alterations in hematopoietic malignancies. Int. J. Hematol. 2012, 96, 413-427.
34. Morin, R.D.; Johnson, N.A.; Severson, T.M.; Mungall, A.J.; An, J.; Goya, R.; Marra, M.A. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet 2010, 42, 181-185.
35. Lund, K.; Adams, P.D.; Copland, M. EZH2 in normal and malignant hematopoiesis. Leukemia 2014, 28, 44-49.
36. Morin, R.D.; Mendez-Lago, M.; Mungall, A.J.; Goya, R.; Mungall, K.L.; Corbett, R.D.; Marra, M.A. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476, 298-303.
37. Sneeringer, C.J.; Scott, M.P.; Kuntz, K.W.; Knutson, S.K.; Pollock, R.M.; Richon, V.M.; Copeland, R.A. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc. Natl. Acad. Sci. USA 2010, 107, 20980-20985.
38. Xiao, M.; Yang, H.; Xu, W.; Ma, S.; Lin, H.; Zhu, H.; Guan, K.-L. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012, 26, 1326-1338.
39. Xu, W.; Yang, H.; Liu, Y.; Yang, Y.; Wang, P.; Kim, S.-H.; Xiong, Y. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 2011, 19, 17-30.
40. Shim, E.-H.; Livi, C.B.; Rakheja, D.; Tan, J.; Benson, D.; Parekh, V.; Sudarshan, S. L-2-hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014, 4, 1290-1298.
41. Lu, C.; Ward, P.S.; Kapoor, G.S.; Rohle, D.; Turcan, S.; Abdel-Wahab, O.; Thompson, C.B. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012, 483, 474-478.
42. Reifenberger, G.; Weber, R.G.; Riehmer, V.; Kaulich, K.; Willscher, E.; Wirth, H.; for the German Glioma Network. Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. Int. J. Cancer 2014, 135, 1822-1831.
43. Weller, M.; Weber, R.; Willscher, E.; Riehmer, V.; Hentschel, B.; Kreuz, M.; Reifenberger, G. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol. 2015, 129, 679-693.
44. Losman, J.-A.; Kaelin, W.G. What a difference a hydroxyl makes: Mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 2013, 27, 836-852.
45. Zhang, J.; Grubor, V.; Love, C.L.; Banerjee, A.; Richards, K.L.; Mieczkowski, P.A.; Dave, S.S. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. USA 2013, 110, 1398-1403.
46. Yun, J.; Johnson, J.L.; Hanigan, C.L.; Locasale, J.W. Interactions between epigenetics and metabolism in cancers. Front. Oncol. 2012, doi:10.3389/fonc.2012.00163.
47. Caro, P.; Kishan, A.U.; Norberg, E.; Stanley, I.A.; Chapuy, B.; Ficarro, S.B.; Polak, K.; Tondera, D.; Gounarides, J.; Yin, H.; et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 2012, 22, 547-560.
48. Jakovcevski, M.; Akbarian, S. Epigenetic mechanisms in neurological disease. Nat. Med. 2012, 18, 1194-1204.
49. Shaknovich, R.; Cerchietti, L.; Tsikitas, L.; Kormaksson, M.; De, S.; Figueroa, M.E.; Melnick, A. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011, 118, 3559-3569.
50. Jin, B.; Ernst, J.; Tiedemann, R.L.; Xu, H.; Sureshchandra, S.; Kellis, M.; Dalton, S.; Liu, C.; Choi, J.H.; Robertson, K.D. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2012, 2, 1411-1424.
51. Williams, K.; Christensen, J.; Helin, K. DNA methylation: TET proteins-Guardians of CpG islands? EMBO Rep. 2012, 13, 28-35.
52. Detich, N.; Theberge, J.; Szyf, M. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 2002, 277, 35791-35794.
53. Wang, G.G.; Konze, K.D.; Tao, J. Polycomb genes, miRNA, and their deregulation in B-cell malignancies. Blood 2015, 125, 1217-1225.
54. Caganova, M.; Carrisi, C.; Varano, G.; Mainoldi, F.; Zanardi, F.; Germain, P.-L.; Casola, S. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J. Clin. Investig. 2013, 123, 5009-5022.
55. Béguelin, W.; Popovic, R.; Teater, M.; Jiang, Y.; Bunting, K.L.; Rosen, M.; Shen, H.; Yang, S.N.; Wang, L.; Ezponda, T.; et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 2013, 23, 677-692.
56. Jiang, W.; Wang, J.; Zhang, Y. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway. Cell Res. 2013, 23, 122-130.
57. Swigut, T.; Wysocka, J. H3K27 Demethylases, at Long Last. Cell 2007, 131, 29-32.
58. De Santa, F.; Totaro, M.G.; Prosperini, E.; Notarbartolo, S.; Testa, G.; Natoli, G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007, 130, 1083-1094.
59. De Santa, F.; Narang, V.; Yap, Z.H.; Tusi, B.K.; Burgold, T.; Austenaa, L.; Natoli, G. Jmjd3 contributes to the control of gene expression in LPS activated macrophages. EMBO J. 2009, 28, 3341-3352.
60. Son, J.; Shen, S.S.; Margueron, R.; Reinberg, D. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin. Genes Dev. 2013, 27, 2663-2677.
61. Shen, X.; Liu, Y.; Hsu, Y.-J.; Fujiwara, Y.; Kim, J.; Mao, X.; Orkin, S.H. EZH1 Mediates Methylation on histone H3 Lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 2008, 32, 491-502.
62. Margueron, R.; Li, G.; Sarma, K.; Blais, A.; Zavadil, J.; Woodcock, C.L.; Reinberg, D. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 2008, 32, 503-518.
63. Henriquez, B.; Bustos, F.J.; Aguilar, R.; Becerra, A.; Simon, F.; Montecino, M.; van Zundert, B. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons. Mol. Cell. Neurosci. 2013, 57, 130-143.
64. Beà, S.; Valdés-Mas, R.; Navarro, A.; Salaverria, I.; Martín-Garcia, D.; Jares, P.; Campo, E. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl. Acad. Sci. USA 2013, 110, 18250-18255.
65. Zhang, J.; Jima, D.; Moffitt, A.B.; Liu, Q.; Czader, M.; Hsi, E.D.; Dave, S.S. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood 2014, 123, 2988-2996.
66. Martinez-Garcia, E.; Popovic, R.; Min, D.-J.; Sweet, S.M.M.; Thomas, P.M.; Zamdborg, L.; Licht, J.D. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 2011, 117, 211-220.
67. Pasqualucci, L.; Trifonov, V.; Fabbri, G.; Ma, J.; Rossi, D.; Chiarenza, A.; Dalla-Favera, R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet 2011, 43, 830-837.
68. Gindin, T.; Murty, V.; Alobeid, B.; Bhagat, G. MLL/KMT2A translocations in diffuse large B-cell lymphomas. Hematol. Oncol. 2014, doi:10.1002/hon.2158.
69. Chen, L.-B.; Xu, J.-Y.; Yang, Z.; Wang, G.-B. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J. Gastroenterol. 2007, 13, 5718-5724.
70. Kidder, B.; Hu, G.; Zhao, K. KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation. Genome Biol. 2014, doi:10.1186/gb- 2014-15-2-r32.
71. Wang, G.G.; Song, J.; Wang, Z.; Dormann, H.L.; Casadio, F.; Li, H.; Allis, C.D. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459, 847-851.
72. Zoabi, M.; Nadar-Ponniah, P.T.; Khoury-Haddad, H.; Usaj, M.; Budowski-Tal, I.; Haran, T.; Ayoub, N. RNA-dependent chromatin localization of KDM4D lysine demethylase promotes H3K9me3 demethylation. Nucl. Acids Res. 2014, doi:10.1093/nar/gku1021.
73. Berry, W.L.; Janknecht, R. KDM4/JMJD2 histone demethylases: Epigenetic regulators in cancer cells. Cancer Res. 2013, 73, 2936-2942.
74. Gregory, B.L.; Cheung, V.G. Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth. Genome Res. 2014, 24, 52-63.
75. Bartke, T.; Vermeulen, M.; Xhemalce, B.; Robson, S.C.; Mann, M.; Kouzarides, T. Nucleosomeinteracting proteins regulated by DNA and histone methylation. Cell 2010, 143, 470-484.
76. Wagner, E.J.; Carpenter, P.B. Understanding the language of Lys36 methylation at histone H3. Nat. Rev. Mol. Cell Biol. 2012, 13, 115-126.
77. Pai, C.-C.; Deegan, R.S.; Subramanian, L.; Gal, C.; Sarkar, S.; Blaikley, E.J.; Humphrey, T.C. A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice. Nat. Commun. 2014, doi:10.1038/ncomms5091.
78. Pfister, S.X.; Ahrabi, S.; Zalmas, L.-P.; Sarkar, S.; Aymard, F.; Bachrati, C.Z.; Humphrey, T.C.; Legube, G.; la Thangue, N.B.; Porter, A.C.; et al. SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability. Cell Rep. 2014, 7, 2006-2018.
79. Slany, R.K. The molecular biology of mixed lineage leukemia. Haematologica 2009, 94, 984-993.
80. Patel, A.; Dharmarajan, V.; Vought, V.E.; Cosgrove, M.S. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J. Biol. Chem. 2009, 284, 24242-24256.
81. Steward, M.M.; Lee, J.-S.; O'Donovan, A.; Wyatt, M.; Bernstein, B.E.; Shilatifard, A. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat. Struct. Mol. Biol. 2006, 13, 852-854.
82. Cao, F.; Chen, Y.; Cierpicki, T.; Liu, Y.; Basrur, V.; Lei, M.; Dou, Y. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS ONE 2010, 5, e14102.
83. Vincenz, C.; Kerppola, T.K. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences. Proc. Natl. Acad. Sci. USA 2008, 105, 16572-16577.
84. Gao, Z.; Zhang, J.; Bonasio, R.; Strino, F.; Sawai, A.; Parisi, F.; Reinberg, D. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family Complexes. Mol. Cell 2012, 45, 344-356.
85. Pasini, D.; Bracken, A.P.; Hansen, J.B.; Capillo, M.; Helin, K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell. Biol. 2007, 27, 3769-3779.
86. Tang, L.; Nogales, E.; Ciferri, C. Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription. Prog. Biophys. Mol. Biol. 2010, 102, 122-128.
87. Hendricks, K.B.; Shanahan, F.; Lees, E. Role for BRG1 in cell cycle control and tumor suppression. Mol. Cell. Biol. 2004, 24, 362-376.
88. Espenshade, P.J. SREBPs: Sterol-regulated transcription factors. J. Cell Sci. 2006, 119, 973-976.
89. Shechter, I.; Dai, P.; Huo, L.; Guan, G. IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: Evidence that IDH1 may regulate lipogenesis in hepatic cells. J. Lipid Res. 2003, 44, 2169-2180.
90. Fragola, G.; Germain, P.-L.; Laise, P.; Cuomo, A.; Blasimme, A.; Gross, F.; Testa, G. Cell reprogramming requires silencing of a core subset of polycomb targets. PLoS Genet. 2013, 9, e1003292.
91. Chen, S.; Shi, Y. A new horizon for epigenetic medicine? Cell Res. 2013, 23, 326-328.
92. Nie, Z.; Hu, G.; Wei, G.; Cui, K.; Yamane, A.; Resch, W.; Levens, D. c-Myc Is a Universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012, 151, 68-79.
93. Rahl, P.B.; Lin, C.Y.; Seila, A.C.; Flynn, R.A.; McCuine, S.; Burge, C.B.; Young, R.A. c-Myc regulates transcriptional pause release. Cell 2010, 141, 432-445.